Impact of Proton Pump Inhibitor Use on Progression-Free and Overall Survival in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis of Recent Studies
Giuliana Ciappina(University of Ferrara), Massimiliano Berretta(University of Messina), Dalila Incognito(University of Messina), Vincenzo Quagliariello(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Pierluigi Consolo, Concetta Zito(University of Messina), Mariachiara Santorsola(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Irene Campo(University of Messina), Anna Paola Capra(University of Messina), Irene Cacciola(University of Messina), Alessandro Ottaiano(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Nicola Maurea(Cancer Institute (WIA)), Carlotta Giorgi(University of Ferrara), Emanuela Esposito(University of Messina), Maria Ilenia Passalacqua(University of Messina), Patrizia Carroccio(University of Messina), Fabiola De Luca(University of Messina)
Cited by 9
Related Papers
Antiinflammatory Activity of Melatonin in Central Nervous System
|Current Neuropharmacology|2010|406
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
Echocardiographic reference ranges for normal non-invasive myocardial work indices: results from the EACVI NORRE study
|European Heart Journal - Cardiovascular Imaging|2018|336
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
|Journal of Hepatology|2019|205
Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective
|Frontiers in Physiology|2018|154